Continued strong Cresemba® (isavuconazole) sales trigger second sales milestone this year from Pfizer to Basilea of USD 7 million

    NEXT STORY
    Half-year report
    PREV STORY
    ASLAN Pharmaceuticals Announces Closing of US$15 Million Public Offering of American Depositary Shares, Including Full Exercise of Underwriter’s Option to Purchase Additional ADSs
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Fortress Biotech Reports First Quarter 2019 Financial Results and Recent Corporate Highlights

    author_avatar
    NASDAQ Market News

    C-RAD AB – Delårsrapport januari-september 2019

    author_avatar
    NASDAQ Market News

    Onconova Therapeutics Announces Positive Phase 2 Data in Rigosertib Treated Patients with Second-line Myelodysplastic Syndromes at the American Society of Clinical Oncology Annual Meeting

    Bone marrow response to rigosertib was evaluated as a surrogate for survival in this ...

    author_avatar
    NASDAQ Market News